Jump to content
Wikipedia The Free Encyclopedia

Pharmahuasca

From Wikipedia, the free encyclopedia
Pharmaceutical version of the traditional Ayahuasca entheogen

Pharmahuasca is a pharmaceutical version of ayahuasca, a psychoactive decoction used by indigenous cultures in South America as part of traditional medicine and shamanism. Traditional ayahuasca is made by brewing the monoamine oxidase inhibitor (MAOI)-containing Banisteriopsis caapi vine with a dimethyltryptamine (DMT)-containing plant, such as Psychotria viridis . Pharmahuasca refers to a similar combination that uses a synthetically produced or pharmaceutical MAOI, such as moclobemide, instead of a plant.

Use and effects

[edit ]

DMT and harmaline or harmine are typically used as components of pharmahuasca.[1] One study tested a formulation of 100 mg buccal harmine with 100 mg intranasal DMT, which produced an effect lasting 2 to 3hours.[1] As a rule, the fewer the β-carbolines, the less nausea; the more DMT, the more spectacular the visions.[citation needed ] The constituents are put into separate gelatin capsules. The capsules with harmaline/harmine are swallowed first and the capsules containing DMT are taken 15 to 20 minutes later. A synthetic MAOI can be used in place of harmaline and harmine, although caution must be taken when choosing an MAOI.[2] The use of moclobemide, a reversible inhibitor of monoamine oxidase-A (RIMA), has been recorded and is safer than older irreversible MAOIs (such as isocarboxazid) due to its significantly shorter and more selective effects (although it still exhibits a wide range of dangerous drug-drug interactions).[3] [4]

Oral doses and durations of β-carbolines or harmala alkaloids
CompoundChemical nameDose (hallucinogen)PotencyDose (MAOI)Duration
Harman 1-Methyl-β-carboline>250 mgUnknown>250 mgUnknown
Harmine 7-Methoxyharman>300 mg≤50%140–250 mg6–8 hours
Harmaline 7-Methoxy-3,4-dihydroharman150–400 mg100%70–150 mg5–8 hours
Tetrahydroharmine 7-Methoxy-1,2,3,4-tetrahydroharman≥300 mg~33%UnknownUnknown
6-Methoxyharmalan 6-Methoxy-3,4-dihydroharman~100 mg~150%UnknownUnknown
6-MeO-THH 6-Methoxy-1,2,3,4-tetrahydroharman≥100 mg~50%UnknownUnknown
P. harmala seeds ≥5–28 ga3–5 gaUnknown
Footnotes: a = P. harmala seeds in ground form. They contain 2–7% harmala alkaloids, with 1teaspoon ≈ 3g ≈ 60–180mg alkaloids; 1tablespoon ≈ 9g ≈ 200–600mg alkaloids; and 1large (OO) gelatin capsule ≈ 0.7g ≈ 15–45mg alkaloids. For comparison, B. caapi contains 0.05–1.95% (average 0.45%) harmala alkaloids. Note: Harmine and other β-carbolines have also been tested by non-oral routes such as sublingual, subcutaneous injection, intramuscular injection, and intravenous injection. Refs: See template page.

Interactions

[edit ]

See also

[edit ]
[edit ]

References

[edit ]
  1. 1 2 Mueller, Michael J.; Aicher, Helena D.; Dornbierer, Dario A.; Marten, Laurenz; Suay, Dila; Meling, Daniel; Elsner, Claudius; Wicki, Ilhui A.; Müller, Jovin; Poetzsch, Sandra N.; Caflisch, Luzia; Hempe, Alexandra; Steinhart, Camilla P.; Puchkov, Maxim; Kost, Jonas (2024年12月28日). "Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial". The International Journal of Neuropsychopharmacology. 28 (1) pyaf001. doi:10.1093/ijnp/pyaf001. ISSN 1469-5111. PMC 11770821 . PMID 39774840.
  2. Ott J. Ayahuasca Analogues: Pangaen Entheogens. Natural Products Co.. 1994. 34
  3. Kaasik, Helle; Souza, Rita C. Z.; Zandonadi, Flávia S.; Tófoli, Luís Fernando; Sussulini, Alessandra (2020年09月08日). "Chemical Composition of Traditional and Analog Ayahuasca". Journal of Psychoactive Drugs. 53 (1): 65–75. doi:10.1080/02791072.2020.1815911. ISSN 2159-9777. PMID 32896230. S2CID 221543172.
  4. Ruffell, Simon; Netzband, Nige; Bird, Catherine; Young, Allan H.; Juruena, Mario F.; Ruffell, Simon; Netzband, Nige; Bird, Catherine; Young, Allan H.; Juruena, Mario F. (2020年07月03日). "The pharmacological interaction of compounds in ayahuasca: a systematic review". Brazilian Journal of Psychiatry. 42 (6): 646–656. doi:10.1590/1516-4446-2020-0884 . ISSN 1516-4446. PMC 7678905 . PMID 32638916.

AltStyle によって変換されたページ (->オリジナル) /